In late June, a few days before Disability Pride Month began, I took my 7-year-old child on an outing to an Ikea store. As I ...

Stoke Therapeutics and Biogen have begun dosing in the global Phase III EMPEROR study of zorevunersen for Dravet syndrome, ...

Isabelle Whitehead, a student at Ripon Grammar School, has earned a place to study medicine, inspired by the care given to ...

Good morning. As AI becomes more widely used in health care, could it actually lead doctors to lose some of their skills? One ...

Cambridge, Massachusetts Wednesday, August 13, 2025, 15:00 Hrs [IST] ...

Stoke Therapeutics Inc (STOK) reports promising advancements in its Dravet syndrome program and strategic partnerships, ...

Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational ...

Under current federal law, cannabis is classified as a Schedule I drug, the same category as heroin and methamphetamine.

Isabelle Whitehead, a student at Ripon Grammar School, has earned a place to study medicine, inspired by the care given to her younger brother ...

Biogen has bolstered its pipeline by licensing ex-US rights to a drug for Dravet syndrome – a rare form of epilepsy – from Stoke Therapeutics in a deal that included an upfront payment of $165 ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $24.5, a high estimate of $30.00, and a low estimate of $22.00. This upward trend is apparent, ...

A young carer soon to be a future doctor as well as a Judo star in North Yorkshire are just two of thousands of students who received top ...